CytomX Therapeutics (CTMX) Net Income Growth (5y) (2019 - 2026)
CytomX Therapeutics (CTMX) Net Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn |
| 10 | CytomX Therapeutics | 598.30 Mn | 251.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.79% |
| Dec 31, 2025 | 1.14% |
| Sep 30, 2025 | 10.68% |
| Jun 30, 2025 | 63.95% |
| Mar 31, 2025 | 19.87% |
| Dec 31, 2024 | 17.98% |
| Sep 30, 2024 | 17.52% |
| Jun 30, 2024 | 25.75% |
| Mar 31, 2024 | 24.38% |
| Dec 31, 2023 | 15.17% |
| Sep 30, 2023 | 16.30% |
| Jun 30, 2023 | 39.53% |
| Mar 31, 2023 | 26.55% |
| Dec 31, 2022 | -74.39% |
| Sep 30, 2022 | -23.18% |
| Jun 30, 2022 | -3.19% |
| Mar 31, 2022 | -31.10% |
| Dec 31, 2021 | -19.93% |
| Sep 30, 2021 | -16.14% |
| Jun 30, 2021 | -13.53% |